Analyst ratings can significantly influence a company's stock price. In this case, Barclays' downgrade of Nutrien's stock from Overweight to Underweight has led to a decrease in the company's share price. This suggests that investors may have lost confidence in the company's performance, leading to a sell-off of the stock.